Henry Schein Animal Health

Henry Schein Animal Health specializes in providing essential veterinary products and services, ensuring operational efficiency for animal healthcare practices worldwide. Henry Schein Animal Health operates as a subsidiary of Henry Schein, Inc. , focusing on veterinary supplies. The company was significantly expanded in January 2012 when it acquired Butler Schein Animal Health for USD 155 mn.

Headquartered in Melville, US, it plays a vital role in the animal health industry. Henry Schein is a leading provider of dental and medical supplies, delivering a diverse range of products and solutions designed to enhance the operational efficiency of healthcare practices. The company's core product offerings include dental consumables, medical supplies, practice management software, and technology solutions aimed at improving clinical outcomes and patient care. These products serve a broad client base, including dental offices, medical practices, hospitals, and laboratories across various geographical markets, such as North America, Europe, and Asia-Pacific.

By integrating advanced technology and expertise, Henry Schein addresses the challenges faced by healthcare professionals, offering tailored solutions that facilitate effective patient management and operational growth. Henry Schein reported USD 12. 7 bn in sales for the year 2024, reflecting its robust position in the healthcare supply sector. The company engages in transactions primarily through a Business-to-Business (B2B) model, supplying its products directly to healthcare providers and institutions.

Clients benefit from a strategic partnership approach, where Henry Schein provides not only products but also support services, including practice management software and training programs. Transactions often involve bulk purchasing agreements and subscription services for software solutions, allowing clients to access a comprehensive suite of tools and resources. Key offerings such as Henry Schein MicroMD and Henry Schein One exemplify the company’s commitment to integrating technology into healthcare practices, enhancing both the operational capabilities and patient outcomes for their clients. Henry Schein plans to leverage its most recent acquisition and the funding from the Trade Sale in January 2012 to enhance its product portfolio in the veterinary market.

The company aims to introduce new products to better serve veterinarians and animal healthcare providers, while also targeting expansion into emerging markets in Asia-Pacific by 2025. This strategy involves utilizing the existing network and resources to create tailored solutions for these regions, further solidifying its presence in the global animal health industry.